3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Topiramate (toe-PYRE-a-mate) is used to help control some types of seizures in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to help control seizures for as long as you continue to take it.


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > AIDS/HIV -

Gut Tissue is Major Reservoir Harboring AIDS

AIDS/HIVAug 28, 06

FINDINGS: UCLA researchers have found the human gut to be a major reservoir harboring the HIV virus - holding almost twice as much as a person’s blood. In addition, the virus stored in the gut does not decay or reduce over time, as is also the case with blood-related reservoirs. It is well-known that peripheral blood mononuclear cells (PBMCs) and lymph nodes are principal reservoirs harboring the human immunodeficiency virus (HIV). The role of gut-associated lymphoid tissue (GALT) in this setting, however, had not been properly evaluated until now. Researchers from the Center for Prevention Research and the UCLA AIDS Institute at the David Geffen School of Medicine at UCLA, in collaboration with the AIDS Research Alliance in West Hollywood, Calif., collaborated on this research.

IMPACT: The findings further confirm that HIV remains persistent and elusive, and that eradicating the virus using current anti-retroviral therapy alone is not enough. Despite using fully suppressive therapy, patients in the study still had evidence of persistent, steady levels of HIV in gut tissue as well as in the blood.

AUTHORS: W. John Boscardin, Julie Elliott, Philip Taing, Marie M.P. Fuerst, Ian McGowan and Peter A. Anton of UCLA; Michael A. Poles of New York University; and Stephen Brown of the AIDS Research Alliance.

JOURNAL: Journal of Acquired Immune Deficiency Syndromes, September issue.

FUNDERS: Grants from the National Institutes of Health’s Centers for AIDS Research (CFAR): Cores of Mucosal Immunology, Virology and Biostatistics; AIDS Research Alliance; Macy’s Foundation; Pendleton Foundation, and Oppenheimer Brothers Foundation.

University of California, Los Angeles (UCLA), Health Sciences



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Protein identified that turns off HIV-fighting T cells
  Study examines repeated exposure to HIV in treatment-suppressed HIV patients
  Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
  What HIV Needs: Identification of Human Factors May Yield Novel Therapeutic Targets for HIV
  HIV Status Unknown for Most “Negative” Men Online
  A Young Woman’s Battle With HIV
  WHO publishes how-to guide on fighting AIDS
  African ex-leaders to press politicians over AIDS
  Mexicans in U.S. illegally at more risk of AIDS
  Government to release revised U.S. HIV estimates
  U.S. drops trial of one AIDS vaccine
  Genetic Variation Raises HIV Risk in People of African Descent

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site